📖

ATP P2X3 Receptor Neurons

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-cell-types-p2x3-receptor-neurons

Related Entities

cell-types-p2x3-receptor-neurons

Metadata

slug	cell-types-p2x3-receptor-neurons
entity_type	cell
kg_node_id	None

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (335)

mentions🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&90%

mentions🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&80%

related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&72%

mentions🧫Germfree mouse colonocyte energy metabolism analysis70%

mentions🧫Proposed experiment from debate on Epigenetic clocks and bio70%

mentions🧫s:** - Test whether HCN1 knockout specifically in EC layer I70%

mentions🧫s:** - GPR32 knockout in microglia should worsen neuroinflam70%

mentions🧫Proposed experiment from debate on Astrocytes adopt A1 (neur70%

mentions🧫s:** - Temporal analysis showing mitochondrial defects prece70%

mentions🧫s:** - Test MCU overexpression specifically in layer II neur70%

mentions🧫Proposed experiment from debate on TDP-43 undergoes liquid-l70%

mentions🧫Proposed experiment from debate on Mitochondrial transfer be70%

mentions🧫Proposed experiment from debate on Perivascular spaces and g70%

mentions🧫Proposed experiment from debate on Mitochondrial transfer be70%

mentions🧫Blood metabolite analysis of purinergic molecules in COVID-170%

mentions🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau70%

mentions🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i70%

mentions🧫Selective Vulnerability of Dopaminergic Neurons — Mechanism 70%

mentions🧫Ferroptosis Validation in Parkinson's Disease70%

mentions🧫Gap Junction Dysfunction Validation in Parkinson's Dise70%

mentions🧫Cytochrome Therapeutics70%

mentions🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr70%

mentions🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 70%

mentions🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise70%

mentions🧫Peroxisomal Dysfunction Validation in Parkinson's Disea70%

mentions🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%

mentions🧫Purinergic Signaling Dysfunction Validation in Parkinson70%

mentions🧫Regulated Necrosis Validation Study in Parkinson's Dise70%

mentions🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 70%

related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&70%

related🧫Germfree mouse colonocyte energy metabolism analysis63%

related🧫Proposed experiment from debate on Epigenetic clocks and bio63%

related🧫s:** - Test whether HCN1 knockout specifically in EC layer I63%

related🧫s:** - GPR32 knockout in microglia should worsen neuroinflam63%

related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur63%

related🧫s:** - Temporal analysis showing mitochondrial defects prece63%

related🧫s:** - Test MCU overexpression specifically in layer II neur63%

related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l63%

related🧫Proposed experiment from debate on Mitochondrial transfer be63%

related🧫Proposed experiment from debate on Perivascular spaces and g63%

related🧫Proposed experiment from debate on Mitochondrial transfer be63%

related🧫Blood metabolite analysis of purinergic molecules in COVID-163%

related🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau63%

related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i63%

related🧫Selective Vulnerability of Dopaminergic Neurons — Mechanism 63%

related🧫Ferroptosis Validation in Parkinson's Disease63%

related🧫Gap Junction Dysfunction Validation in Parkinson's Dise63%

related🧫Cytochrome Therapeutics63%

related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr63%

related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 63%

related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise63%

related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea63%

related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin63%

related🧫Purinergic Signaling Dysfunction Validation in Parkinson63%

related🧫Regulated Necrosis Validation Study in Parkinson's Dise63%

related🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 63%

see_also📖acc-chronic-pain60%

see_also📖ABCA1 - ATP-Binding Cassette Transporter A160%

see_also📖ABCB1 (MDR1) - ATP Binding Cassette Subfamily B Member 160%

see_also📖abcd160%

see_also📖ACO2 — Aconitase 260%

see_also📖BRD4 (Bromodomain-Containing Protein 4)60%

see_also📖CASP4 Gene60%

see_also📖CEBPB Gene60%

see_also📖COX15 — Cytochrome C Oxidase Assembly Factor 1560%

see_also📖DHODH — Dihydroorotate Dehydrogenase60%

see_also📖DYRK1A Gene - Dual Specificity Tyrosine-Phosphorylation Regu60%

see_also📖EGR1 Gene60%

see_also📖FER Gene60%

see_also📖FOXG1 — Forkhead Box G160%

see_also📖FSP1 Gene - Ferroptosis Suppressor Protein 160%

see_also📖GAL Gene60%

see_also📖GAP43 Gene60%

see_also📖GCH1 Gene60%

see_also📖GLUD1 - Glutamate Dehydrogenase 160%

see_also📖HSPA9 Gene60%

see_also📖IGF2BP260%

see_also📖JNK1 (MAPK8)60%

see_also📖LARS2 — Leucyl-tRNA Synthetase 2, Mitochondrial60%

see_also📖LONP160%

see_also📖LRPPRC — Leucine-Rich Pentatricopeptide Repeat Containing60%

see_also📖MAF - MAFA BZIP Transcription Factor60%

see_also📖MAVS Gene60%

see_also📖MCU Gene60%

see_also📖MERTK - MER Tyrosine Kinase60%

see_also📖NEK7 Gene60%

see_also📖NLRC4 Gene60%

see_also📖NRF1 Gene60%

see_also📖OGT — O-GlcNAc Transferase60%

see_also📖OSMR Gene60%

see_also📖P2RY1 Gene60%

see_also📖Purinergic Receptor P2X 7 (P2X7)60%

see_also📖PEX3 Gene - Peroxisome Biogenesis Factor 360%

see_also📖PGK1 Gene60%

see_also📖POLE — DNA Polymerase Epsilon60%

see_also📖PPP1R7 — SDS22 (Protein Phosphatase 1 Regulatory Subunit 7)60%

see_also📖rab3c Gene60%

see_also📖RAPTOR Gene60%

see_also📖RPL4 — Ribosomal Protein L460%

see_also📖S100A8 - S100 Calcium Binding Protein A860%

see_also📖S100A9 - S100 Calcium Binding Protein A960%

see_also📖SDHA Gene - Succinate Dehydrogenase Complex Subunit A60%

see_also📖SIRT6 Gene60%

see_also📖SOCS3 - Suppressor of Cytokine Signaling 360%

see_also📖stmn260%

see_also📖SUCLG1 — Succinate-CoA Ligase GDP Forming Subunit Alpha60%

see_also📖VDAC1 — Voltage Dependent Anion Channel 160%

see_also📖VHL Gene60%

see_also📖VPS16 Gene60%

see_also📖VPS33A Gene60%

see_also📖YBX1 Gene60%

see_also📖ACLY Inhibition Rescues Alpha-Synuclein Autophagy60%

see_also📖Hippo Signaling in 4R-Tauopathies60%

see_also📖CASP4 Protein60%

see_also📖COX15 Protein60%

see_also📖LRP2 Protein (Megalin)60%

see_also📖p2x760%

see_also📖Stathmin 2 (SCG10) Protein60%

see_also📖Uncoupling Protein 2 (UCP2)60%

see_also📖VPS16 Protein60%

see_also📖acc-chronic-pain60%

see_also📖ARC-IM Adaptive Neurostimulation for PD60%

see_also📖metformin-add-on-levodopa-pd-nct0705595860%

see_also📖ADORA2B Gene60%

see_also📖CCS Gene60%

see_also📖ERK2 (MAPK1)60%

see_also📖p2rx160%

see_also📖P2RX4 Gene60%

see_also📖P2RX5 Gene60%

see_also📖PANX1 Gene60%

see_also📖slc17a960%

see_also📖PANX1 Protein60%

see_also📖CYTC60%

see_also📖slc17a7 Gene60%

see_also📖NAD+ Bioenergetics Investment Synthesis60%

see_also📖NAD+ Metabolism in Neurodegeneration60%

see_also📖NAD+ Metabolism Pathway in Neurodegeneration60%

see_also📖NAD+ Boosters for Neurodegeneration60%

see_also📖NAD+ Precursor Therapy for Neurodegenerative Diseases60%

see_also📖NAD+ Precursors for Neurodegeneration60%

see_also📖NAD+ Precursors (NMN/NR) for Parkinson's Disease60%

see_also📖acetylcholine60%

see_also📖ABCG1 Gene60%

see_also📖DYSF — Dysferlin60%

see_also📖GNAL — Gαolf Subunit60%

see_also📖MYOT Gene60%

see_also📖Hepsin Protein60%

see_also📖IRE1/ERN1 (Inositol-Requiring Enzyme 1)60%

see_also📖MAG Gene60%

see_also📖MBP - Myelin Basic Protein60%

see_also📖MOG Gene60%

see_also📖Cerebellum60%

see_also📖ATF4 Gene60%

see_also📖P2RY14 Gene - Purinergic Receptor P2Y1460%

see_also📖Dynein Motor Protein60%

see_also📖Dynein — Cytoplasmic Dynein 160%

see_also📖FASN Gene60%

see_also📖gclc60%

see_also📖AIF Gene60%

see_also📖ATF2 — Activating Transcription Factor 260%

see_also📖BBC360%

see_also📖BRCA1 Gene60%

see_also📖CAMKK2 Gene60%

see_also📖CDKN1A — Cyclin-Dependent Kinase Inhibitor 1A60%

see_also📖eno160%

see_also📖RPS6KB1 Gene60%

see_also📖SCD1 Gene60%

see_also📖STAR — Steroidogenic Acute Regulatory Protein60%

see_also📖UCP2 — Uncoupling Protein 260%

see_also📖vdr60%

see_also📖PP2A (Redirect)60%

see_also📖ABCD3 Gene60%

see_also📖ARG1 — Arginase 160%

see_also📖BCL2L11 Gene60%

see_also📖DEPTOR60%

see_also📖DISC1 — Disrupted in Schizophrenia 160%

see_also📖EIF2S1 (eIF2α)60%

see_also📖eif4ebp160%

see_also📖EMD — Emerin60%

see_also📖EPAS1 Gene60%

see_also📖FAM134B — Family With Sequence Similarity 134 Member B60%

see_also📖GRB2 — Growth Factor Receptor Bound Protein 260%

see_also📖HSPA5 — Heat Shock Protein Family A (Hsp70) Member 560%

see_also📖IFNG Gene60%

see_also📖IRF3 Gene60%

see_also📖MAP1LC3A Gene60%

see_also📖MLST8 Gene60%

see_also📖MUL1 Gene60%

see_also📖PP2A (PPP2R1A)60%

see_also📖RHEB Gene60%

see_also📖RICTOR Gene60%

see_also📖RPTOR — Regulatory Associated Protein of MTOR Complex 160%

see_also📖RTN3 Gene60%

see_also📖SESN2 Gene60%

see_also📖SNCAIP Gene60%

see_also📖PARL Protein60%

see_also📖PP2A Protein60%

see_also📖RICTOR Protein60%

see_also📖Mitochondrial Dynamics60%

see_also📖mitochondrial-dynamics60%

see_also📖Mitochondrial Dynamics in Neurodegeneration60%

see_also📖ITPR2 Gene60%

see_also📖ABCG4 Gene — ATP-Binding Cassette Subfamily G Member 460%

see_also📖cftr60%

see_also📖LRP2 — Low Density Lipoprotein Receptor-Related Protein 2 (M60%

see_also📖MST1 Gene60%

see_also📖NRG1 Gene60%

see_also📖PRKAA2 (AMPKα2) — AMP-Activated Protein Kinase Catalytic Sub60%

see_also📖RPS6 Gene60%

see_also📖RUBCN Gene60%

see_also📖ACO2 — Aconitase 260%

see_also📖CYCS60%

see_also📖DEPDC5 Gene60%

see_also📖JNK2 (MAPK9)60%

see_also📖JNK3 (MAPK10)60%

see_also📖NDUFS1 Gene60%

see_also📖NDUFS2 Gene60%

see_also📖LRPPRC Protein60%

see_also📖ABCA7 (Redirect)60%

mentions🧪Microbial Inflammasome Priming Prevention50%

mentions🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro50%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%

mentions🧪Competitive APOE4 Domain Stabilization Peptides50%

mentions🧪APOE Isoform Expression Across Glial Subtypes50%

mentions🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 50%

mentions🧪Glymphatic System-Enhanced Antibody Clearance Reversal50%

mentions🧪SASP-Driven Aquaporin-4 Dysregulation50%

mentions🧪Aquaporin-4 Polarization Rescue50%

mentions🧪Circadian Rhythm Entrainment of Reactive Astrocytes50%

mentions🧪Chromatin Accessibility Restoration via BRD4 Modulation50%

mentions🧪Temporal Decoupling via Circadian Clock Reset50%

mentions🧪Circadian Clock-Autophagy Synchronization50%

mentions🧪FOXO3-Longevity Pathway Epigenetic Reprogramming50%

mentions🧪Stress Granule Phase Separation Modulators50%

mentions🧪Phase-Separated Organelle Targeting50%

mentions🧪RNA Granule Nucleation Site Modulation50%

mentions🧪CX43 hemichannel engineering enables size-selective mitochon50%

mentions🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho50%

mentions🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition50%

mentions🧪Metabolic Switch Targeting for A1→A2 Repolarization50%

mentions🧪Lysosomal Positioning Dynamics Modulation50%

mentions🧪Mitochondrial Transfer Pathway Enhancement50%

mentions🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai50%

mentions🧪Microglial Purinergic Reprogramming50%

mentions🧪Purinergic P2Y12 Inverse Agonist Therapy50%

mentions🧪Extracellular Matrix Stiffness Modulation50%

mentions🧪Perforant Path Presynaptic Terminal Protection Strategy50%

mentions🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho50%

mentions🧪Mitochondrial-Lysosomal Contact Site Engineering50%

mentions🧪Nutrient-Sensing Epigenetic Circuit Reactivation50%

mentions🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration50%

mentions🧪SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK50%

mentions🧪SIRT6-NAD+ Axis Enhancement Therapy50%

mentions🧪TFAM overexpression creates mitochondrial donor-recipient gr50%

mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination50%

mentions🧪TREM2-mediated microglial tau clearance enhancement50%

mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia50%

mentions🧪Senescent Cell Mitochondrial DNA Release50%

mentions🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem50%

mentions🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener50%

mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming50%

mentions🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto50%

mentions🧪Magnetosonic-Triggered Transferrin Receptor Clustering50%

related🔬What are the mechanisms underlying selective vulnerability o50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

related🔬What are the mechanisms underlying senolytic therapy for age50%

related🔬What are the mechanisms underlying perivascular spaces and g50%

related🔬What are the mechanisms underlying selective vulnerability o50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

related🔬What are the mechanisms underlying senolytic therapy for age50%

related🔬What are the mechanisms underlying mitochondrial transfer be50%

related🔬What are the mechanisms underlying perivascular spaces and g50%

related🔬Epigenetic reprogramming in aging neurons50%

related🔬What cell types are most vulnerable in Alzheimers Disease ba50%

related🔬What cell types are most vulnerable in Alzheimer's Dise50%

related🔬Why do entorhinal cortex layer II stellate neurons die first50%

related🔬Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% br50%

related🔬Mitochondrial transfer between astrocytes and neurons50%

related🔬What are the mechanisms underlying rna binding protein dysre50%

related🔬What gene expression changes in the aging mouse brain predic50%

related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%

mentions🧫RBG treatment in ApoE-/- atherosclerosis mouse model44%

mentions🧫Leukocyte gene expression analysis in COVID-19 patients44%

mentions🔬Epigenetic reprogramming in aging neurons40%

mentions🔬What are the mechanisms underlying selective vulnerability o40%

mentions🔬What are the mechanisms underlying mitochondrial transfer be40%

mentions🔬Why do entorhinal cortex layer II stellate neurons die first40%

mentions🔬Mitochondrial transfer between astrocytes and neurons40%

mentions🔬Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% br40%

mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%

mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%

related🧪Senescent Cell Mitochondrial DNA Release40%

related🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem40%

related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener40%

related🧪Synthetic Biology BBB Endothelial Cell Reprogramming40%

related🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto40%

related🧪Magnetosonic-Triggered Transferrin Receptor Clustering40%

related🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro40%

related🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 40%

related🧪Chromatin Accessibility Restoration via BRD4 Modulation40%

related🧪FOXO3-Longevity Pathway Epigenetic Reprogramming40%

related🧪Liquid-Liquid Phase Separation Modifier Therapy40%

related🧪Stress Granule Phase Separation Modulators40%

related🧪Phase-Separated Organelle Targeting40%

related🧪RNA Granule Nucleation Site Modulation40%

related🧪CX43 hemichannel engineering enables size-selective mitochon40%

related🧪Astrocytic Connexin-43 Upregulation Enhances Neuroprotective40%

related🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho40%

related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition40%

related🧪Metabolic Switch Targeting for A1→A2 Repolarization40%

related🧪Mitochondrial Calcium Buffering Enhancement via MCU Modulati40%

related🧪Mitochondrial Transfer Pathway Enhancement40%

related🧪Oligodendrocyte White Matter Vulnerability40%

related🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai40%

related🧪Gap Junction Hemichannel Modulation for Controlled Mitochond40%

related🧪Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption40%

related🧪Extracellular Matrix Stiffness Modulation40%

related🧪Perforant Path Presynaptic Terminal Protection Strategy40%

related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho40%

related🧪Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy40%

related🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration40%

related🧪SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK40%

related🧪SIRT6-NAD+ Axis Enhancement Therapy40%

related🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation40%

related🧪Serine/Arginine-Rich Protein Kinase Modulation40%

related🧪TFAM overexpression creates mitochondrial donor-recipient gr40%

related🧪Age-Dependent Complement C4b Upregulation Drives Synaptic Vu35%

related🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto35%

related🧪Magnetosonic-Triggered Transferrin Receptor Clustering35%